Workflow
MarketWatch
icon
Search documents
Why investors aren't loving this January jobs report
MarketWatch· 2026-02-11 17:33
Core Insights - Volatility has returned to Wall Street, driven by a surprisingly strong jobs report for January [1] Group 1 - The strong jobs report is a central factor contributing to the day's market turbulence [1]
Micron's stock pops. Here's what an executive just said to calm nervous investors.
MarketWatch· 2026-02-11 17:30
Core Viewpoint - The memory-chip maker has commenced high-volume production of its HBM4 and has started shipping to customers, as stated by CFO Mark Murphy [1] Group 1 - The company is actively producing HBM4 memory chips in large quantities [1] - Shipments of HBM4 to customers have already begun [1]
Why Amazon's $6.5 billion chip deal with Astera Labs is a ‘double-edged sword'
MarketWatch· 2026-02-11 16:22
Core Viewpoint - Astera Labs' shares declined despite exceeding fourth-quarter earnings expectations, as investors expressed skepticism regarding the value of a significant deal with Amazon [1] Group 1: Earnings Performance - Astera Labs reported a fourth-quarter earnings beat, indicating stronger-than-expected financial performance [1] Group 2: Investor Sentiment - Investors raised concerns about the rationale behind the large deal with Amazon, leading to a drop in share prices [1]
20 stocks of companies that delivered a double dose of growth this earnings season
MarketWatch· 2026-02-11 15:45
Companies in the S&P 500 achieving double-digit sales growth while improving profit margins include Palantir, Micron, Boeing and Alphabet. ...
Moderna's work developing seasonal vaccines is ‘risky' under current FDA, analyst says
MarketWatch· 2026-02-11 15:44
Core Viewpoint - Moderna's development of seasonal vaccines is considered 'risky' due to the FDA's refusal to review its mRNA-based flu vaccine application, reflecting a conflict between the company's mRNA-centric approach and the U.S. government's changing stance on mRNA technology [1] Group 1: Company Challenges - Moderna faces increasing pressure to expand its business as COVID-19 vaccine sales decline [1] - The FDA's decision not to review the flu vaccine application is a significant setback for Moderna's mRNA development efforts [1] - The company has described the FDA's communication as "inconsistent," indicating potential challenges in regulatory interactions [1] Group 2: Industry Context - The situation highlights the broader risks associated with mRNA technology in the current regulatory environment [1] - Analysts suggest that the shifting views of the U.S. government on mRNA technology pose risks for companies like Moderna that are heavily invested in this area [1]
Coal stocks gain as Trump looks set to issue executive order calling for industry deals with military
MarketWatch· 2026-02-11 15:42
Core Viewpoint - Coal stocks experienced an increase following the announcement that President Donald Trump intends to sign an executive order that may benefit the coal industry [1] Group 1 - The executive order is expected to provide support to the coal industry, which has been facing challenges in recent years [1] - The news has positively impacted coal stock prices, indicating investor optimism regarding potential regulatory relief [1]
Here's what gold has in common with some other commodities — and what it doesn't
MarketWatch· 2026-02-11 14:21
Core Insights - Governments have become increasingly aware of the importance of energy and food supplies due to the pandemic and the war in Ukraine [1] Group 1 - The pandemic has heightened awareness regarding energy supplies [1] - The war in Ukraine has intensified concerns about food supplies [1]
T-Mobile sees huge boom in phone subscribers, but here's why the stock is falling
MarketWatch· 2026-02-11 13:58
Core Insights - T-Mobile US reported 962,000 net additions of postpaid phone subscribers, which is the company's best performance for a fourth quarter, although it fell short of Wall Street's expectations [1] Company Performance - The net additions of 962,000 postpaid phone subscribers indicate strong demand, but the figure did not meet analysts' forecasts [1]
Kraft Heinz puts separation plans on hold so it can focus on fixing these problems
MarketWatch· 2026-02-11 13:25
Group 1 - Kraft Heinz's stock has declined due to disappointing sales figures, particularly in the North American market [1] - The company's performance continues to struggle, indicating ongoing challenges in meeting market expectations [1] - Analysts are concerned about the sustainability of Kraft Heinz's growth amid these sales disappointments [1]